4.7 Article

Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens

J. A. Sutcliffe et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Microbiology

Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic

Trudy H. Grossman et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Review Infectious Diseases

Colistin pharmacokinetics: the fog is lifting

W. Couet et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

Article Infectious Diseases

Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration

David Landman et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Article Immunology

The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

David N. Gilbert et al.

CLINICAL INFECTIOUS DISEASES (2010)

Review Microbiology

Polymyxins revisited

David Landman et al.

CLINICAL MICROBIOLOGY REVIEWS (2008)

Article Infectious Diseases

Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Neil Woodford et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)